Centrality in Collaboration: A Novel Algorithm for Social Partitioning Gradients in Community Detection for Multiple Oncology Clinical Trial Enrollments

Benjamin Smith, Tyler Pittman, Wei Xu · 2024

Read Centrality in Collaboration: A Novel Algorithm for Social Partitioning Gradients in Community Detection for Multiple Oncology Clinical Trial Enrollments by Benjamin Smith, Tyler Pittman, Wei Xu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2411-01394.txt.

Description

Abstract Patients at a comprehensive cancer center who do not achieve cure or remission following standard treatments often become candidates for clinical trials. Patients who participate in a clinical trial may be suitable for other studies. A key factor influencing patient enrollment in subsequent clinical trials is the structured collaboration between oncologists and most responsible physicians.

Catalog record

CREATORBenjamin Smith, Tyler Pittman, Wei Xu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2411-01394

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Centrality in Collaboration: A Novel Algorithm for Social Partitioning Gradients in Community Detection for Multiple Oncology Clinical Trial Enrollments Benjamin Smith, Tyler Pittman, Wei Xu Abstract Patients at a comprehensive cancer center who do not achieve cure or remission following standard treatments often become candidates for clinical trials. Patients who participate in a clinical trial may be suitable for other studies. A key factor influencing patient enrollment in subsequent clinical trials is the structured collaboration between oncologists and most responsible physicians. Possible identification of these collaboration networks can be achieved through the analysis of patient movements between clinical trial intervention types with social network analysis and community detection algorithms. In the detection of oncologist working groups, the present study evaluates three community detection algorithms: Girvan-Newman, Louvain and an algorithm developed by the author. Girvan-Newman identifies each intervention as their own community, while Louvain groups interventions in a manner that is difficult to interpret. In contrast, the author’s algorithm groups interventions in a way that is both intuitive and informative, with a gradient evident in social partitioning that is particularly useful for epidemiological research. This lays the groundwork for future subgroup analysis of clustered interventions. 1 Introduction When cancer patients complete standard treatments, and have not responded with being cured or in remission, they become candidates for clinical trials. These clinical trials are regulated studies registered by Health Canada 1 1 1 For more information, see https://www.canada.ca/en/health-canada/services/clinical-trials.html as opposed to quality assurance studies 2 2 2 Quality assurance studies in the context of medical studies are studies which look at drugs which are already approved for use, but the goals are focused on other aspects of care such as drug delivery or quality of care. . Patients who qualify may have been screen failures for other trials, have experienced progressive disease, or are receiving maintenance therapy and have been referred to a clinical trial by their oncologist or most responsible physician. Ground truth shows that collaboration networks between oncologists is a primary factor for further engagement in subsequent clinical trials by patients after completion of the given clinical trial that they are enrolled in. A possible approach to understanding the structure of these collaboration networks is through use of social network analysis (SNA) and community detection algorithms. Social network analysis examines individual entities and their relationships among them. The data is represented as a “graph” where individual entities are referred to as “nodes” and their relationships between them as “edges”, which may be directional if specified (see Figure 1). A primary area of study in SNA is the analysis of interconnectivity of nodes, called ”communities” and identification of clusters through the use of algorithms called ”community detection algorithms”. Rostami et al 1 (2023) note that there is no specific model which describes exactly what a ”community” is. Generally, community detection algorithms employ specific optimization strategies to partition a large-scale complex network into a set of disjoint and compact subgroups, often (but not always) without prior knowledge regarding the number of subgroups and their sizes. Rostami et al further note that it is commonly acknowledged that there is no unique community detection algorithm that can accommodate all kinds of graphs, because of the inherent variability in network structures and their respective objective(s). Figure 1: Two simple graphs with directed and undirected edges. Direction is noted by arrowheads at the end of the edges. Application of community detection algorithms with oncology clinical trial data has been preformed in the past. Georgiev et al 2 (2011) applied the Girvan-Newman 3 (2002) algorithm and noted a lack of cohesion among researchers who studied treatments for multiple myeloma. Haq and Wang 4 (2016) applied the Louvain algorithm (by Blondel et al 5 (2008)) to identify communities of cancer patients with significantly different survival curves. The present study applies SNA, and compares multiple community detection algorithms to identify collaboration networks between oncologists through the interventions studied in clinical trials via enrollment data of patients in multiple, nonconcurrent clinical trials. Inspired by work from Gorgiev et al (2011), Haq and Wang (2016), Ostovari and Yu 6 (2019) and Bissoyi and Patra 7 (2020) this research considers the Girvan-Newman and Louvain algorithms and compares them to an author-developed algorithm, referred to as ”Smith-Pittman” 3 3 3 Named after the author and his co-supervisor, Tyler Pittman. , to identify collaboration networks between clinical trials classified by intervention. 2 Materials and Methods 2.1 The Data The data is simulated oncology clinical trials. There were 2970 patients enrolled in 515 clinical trials involving 41 principal investigators. For the identification of collaboration networks between oncologists, the analytic sample only consists of patients who were enrolled in more than one clinical trial within the time period studied. The resulting analytic sample consists of 389 patients enrolled in 288 clinical trials. Among these clinical trials, some interventions can be classified into broader categories of targeted therapies, or immunotherapy. This has been identified in the data with “T:” and “I:” prefixes respectively. The clinical trials were classified by intervention type, presenting as 16 distinct intervention types among 470 patient enrollments. With this classification, the patient referral graph is constructed (see Figure 2). The analysis is preformed with the R programming language, and makes use of an extensive array of libraries and dependencies. The primary libraries that were utilized include igraph , tidyverse , and tidygraph . For the complete script, please refer to the Appendix - Program Syntax. Figure 2: Patient movement between clinical trials classified by intervention type at PM. Nodes indicate the treatment type, and labeled edges indicate the movement (subsequent enrollment) of patients between clinical trials in a given intervention of the same type (self loop), or differing. Among the clinical trials, some interventions can be classified into broader categories consisting of targeted therapies or immunotherapy. This has been identified in the data with “T:” and “I:” prefixes respectively. 2.2 Methods The goal of applying community detection algorithms with this data is to identify oncologist working groups among treatment interventions, based on the movement (incoming and outgoing referrals) of patients between the intervention types. These movements in the network are understood through measures that are considered by the community detection algorithms’ optimization strategies. While the Girvan-Newman, Louvain and Smith-Pittman algorithms differ in their approaches to the identification of collaboration networks, their identification strategies are based on the maximization of modularity, Q - a measure that scores the degree of segregation within a network through tightly connected communities or clusters (See Newman 8 (2006)). The mathematical representation of modularity is defined in the igraph R package 9 (2006) as: Q=\frac{1}{m}\sum_{i,j}\left(A_{ij}-\frac{k_{i}^{\text{out}}k_{j}^{\text{in}}}{m}\right)\delta\left(c_{i},c_{j}\right) Where m is the number of edges (patient movements), A_{ij} is the number of connections shared by nodes i and j (movements between interventions i and j ), k_{i}^{\text{out}} and k_{j}^{\text{in}} are the number of edges coming out from node i and going into node j (patient movements from intervention i and j ) and \delta\left(c_{i},c_{j}\right) is an indicator variable identifying if nodes i and j are connected - either directly or through another node (if there is a patient movement between interventions i and j either directly or through some other intervention). For directed graphs, k_{i}^{\text{out}} and k_{j}^{\text{in}} are simply the number of

Read the complete text